290 related articles for article (PubMed ID: 21124875)
1. Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria.
Stephens R; Langhorne J
PLoS Pathog; 2010 Nov; 6(11):e1001208. PubMed ID: 21124875
[TBL] [Abstract][Full Text] [Related]
2. Early effector cells survive the contraction phase in malaria infection and generate both central and effector memory T cells.
Opata MM; Carpio VH; Ibitokou SA; Dillon BE; Obiero JM; Stephens R
J Immunol; 2015 Jun; 194(11):5346-54. PubMed ID: 25911759
[TBL] [Abstract][Full Text] [Related]
3. Protection by and maintenance of CD4 effector memory and effector T cell subsets in persistent malaria infection.
Opata MM; Ibitokou SA; Carpio VH; Marshall KM; Dillon BE; Carl JC; Wilson KD; Arcari CM; Stephens R
PLoS Pathog; 2018 Apr; 14(4):e1006960. PubMed ID: 29630679
[TBL] [Abstract][Full Text] [Related]
4. Chronic Plasmodium chabaudi Infection Generates CD4 Memory T Cells with Increased T Cell Receptor Sensitivity but Poor Secondary Expansion and Increased Apoptosis.
Opata MM; Stephens R
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031266
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.
Malu DT; Bélanger B; Desautels F; Kelendji K; Dalko E; Sanchez-Dardon J; Leng L; Bucala R; Satoskar AR; Scorza T
J Immunol; 2011 Jun; 186(11):6271-9. PubMed ID: 21518974
[TBL] [Abstract][Full Text] [Related]
6. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
7. Bcl6 is essential for the generation of long-term memory CD4+ T cells.
Ichii H; Sakamoto A; Arima M; Hatano M; Kuroda Y; Tokuhisa T
Int Immunol; 2007 Apr; 19(4):427-33. PubMed ID: 17307796
[TBL] [Abstract][Full Text] [Related]
8. Anti-IL-2 treatment impairs the expansion of T(reg) cell population during acute malaria and enhances the Th1 cell response at the chronic disease.
Zago CA; Bortoluci KR; Sardinha LR; Pretel FD; Castillo-Méndez SI; Freitas do Rosário AP; Hiyane MI; Muxel SM; Rodriguez-Málaga SM; Abrahamsohn IA; Álvarez JM; D'Império Lima MR
PLoS One; 2012; 7(1):e29894. PubMed ID: 22272258
[TBL] [Abstract][Full Text] [Related]
9. Long-Lived CD4+IFN-γ+ T Cells rather than Short-Lived CD4+IFN-γ+IL-10+ T Cells Initiate Rapid IL-10 Production To Suppress Anamnestic T Cell Responses during Secondary Malaria Infection.
Villegas-Mendez A; Inkson CA; Shaw TN; Strangward P; Couper KN
J Immunol; 2016 Oct; 197(8):3152-3164. PubMed ID: 27630165
[TBL] [Abstract][Full Text] [Related]
10. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway.
Taylor-Robinson AW; Smith EC
Immunology; 1999 Mar; 96(3):498-504. PubMed ID: 10233733
[TBL] [Abstract][Full Text] [Related]
11. The spleen CD4+ T cell response to blood-stage Plasmodium chabaudi malaria develops in two phases characterized by different properties.
Muxel SM; Freitas do Rosário AP; Zago CA; Castillo-Méndez SI; Sardinha LR; Rodriguez-Málaga SM; Câmara NO; Álvarez JM; Lima MR
PLoS One; 2011; 6(7):e22434. PubMed ID: 21814579
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ and IL-21 Double Producing T Cells Are Bcl6-Independent and Survive into the Memory Phase in Plasmodium chabaudi Infection.
Carpio VH; Opata MM; Montañez ME; Banerjee PP; Dent AL; Stephens R
PLoS One; 2015; 10(12):e0144654. PubMed ID: 26646149
[TBL] [Abstract][Full Text] [Related]
13. CD49d marks Th1 and Tfh-like antigen-specific CD4+ T cells during Plasmodium chabaudi infection.
Jian JY; Inoue SI; Bayarsaikhan G; Miyakoda M; Kimura D; Kimura K; Nozaki E; Sakurai T; Fernandez-Ruiz D; Heath WR; Yui K
Int Immunol; 2021 Jul; 33(8):409-422. PubMed ID: 33914894
[TBL] [Abstract][Full Text] [Related]
14. Transient deficiency of dendritic cells results in lack of a merozoite surface protein 1-specific CD4 T cell response during peak Plasmodium chabaudi blood-stage infection.
Sponaas AM; Belyaev N; Falck-Hansen M; Potocnik A; Langhorne J
Infect Immun; 2012 Dec; 80(12):4248-56. PubMed ID: 23006847
[TBL] [Abstract][Full Text] [Related]
15. Activation and IL-10 production of specific CD4
Sukhbaatar O; Kimura D; Miyakoda M; Nakamae S; Kimura K; Hara H; Yoshida H; Inoue SI; Yui K
Parasitol Int; 2020 Feb; 74():101994. PubMed ID: 31634628
[TBL] [Abstract][Full Text] [Related]
16. P2X7 receptor drives Th1 cell differentiation and controls the follicular helper T cell population to protect against Plasmodium chabaudi malaria.
Salles ÉM; Menezes MN; Siqueira R; Borges da Silva H; Amaral EP; Castillo-Méndez SI; Cunha I; Cassado ADA; Vieira FS; Olivieri DN; Tadokoro CE; Alvarez JM; Coutinho-Silva R; D'Império-Lima MR
PLoS Pathog; 2017 Aug; 13(8):e1006595. PubMed ID: 28859168
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection.
Linke A; Kühn R; Müller W; Honarvar N; Li C; Langhorne J
Exp Parasitol; 1996 Nov; 84(2):253-63. PubMed ID: 8932775
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice.
Gao W; Sun X; Li D; Sun L; He Y; Wei H; Jin F; Cao Y
Int Immunopharmacol; 2020 Dec; 89(Pt B):107096. PubMed ID: 33091818
[TBL] [Abstract][Full Text] [Related]
19. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion.
Cambos M; Bélanger B; Jacques A; Roulet A; Scorza T
Int J Parasitol; 2008 Feb; 38(2):229-38. PubMed ID: 17868677
[TBL] [Abstract][Full Text] [Related]
20. IFN-γ-induced priming maintains long-term strain-transcending immunity against blood-stage Plasmodium chabaudi malaria.
da Silva HB; de Salles EM; Panatieri RH; Boscardin SB; Rodríguez-Málaga SM; Alvarez JM; D'Império Lima MR
J Immunol; 2013 Nov; 191(10):5160-9. PubMed ID: 24133169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
